Holen Sie sich die Stockscreener-App
2.00
8.68%
-0.19
Finanzdaten der Kalaris Therapeutics Inc-Aktie (KLRS)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-07-01 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Operating Expenses |
4.67%
12.39
|
11.83 | 10.80 | 12.74 | 12.26 |
| Interest Income/Expense |
-
|
- | - | - | - |
| Operating Income/Loss |
4.67%
-12.39
|
-11.83 | -10.80 | -12.74 | -12.26 |
| Nonoperating Income/Loss |
10.85%
0.871
|
0.977 | 0.803 | 0.847 | 0.906 |
| Net Income/Loss |
6.07%
-11.52
|
-10.86 | -9.998 | -11.89 | -11.35 |
| Basic Average Shares |
0.31%
23.80
|
23.72 | - | 18.70 | 18.70 |
| Diluted Average Shares |
0.31%
23.80
|
23.72 | - | 18.70 | 18.70 |
| Basic Earnings Per Share |
4.35%
-0.48
|
-0.46 | - | -0.64 | -0.61 |
| Diluted Earnings Per Share |
4.35%
-0.48
|
-0.46 | - | -0.64 | -0.61 |
4.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):